Drug-induced lupus: simvastatin or amiodarone? A case report in elderly
DOI:
https://doi.org/10.7175/cmi.v7i1.644Keywords:
Drug-induced lupus, Statins, Amiodarone, Systemic lupus erythematosus, Autoimmunity, AutoantibodiesAbstract
Reports of systemic lupus erythematosus (SLE) seen during treatment with amiodarone are rare in the literature. SLE or immunological abnormalities induced by treatment with statins are more frequent. In this issue we report a case of a 81-year-old male who, after a 2-year therapy with amiodarone, developed a clinical and serologic picture of drug-induced SLE (DILE). He was admitted for congestive heart failure in mechanical aortic valve prosthesis, permanent atrial fibrillation (anticoagulation with warfarin), hypercholesterolaemia, and hypothyroidism. Amiodarone was started two years earlier for polymorphic ventricular tachycardia, statin and L-thyroxine the following year. At admission he presented pleuro-pericardical effusion detected by CT-scan (also indicative of interstitial lung involvement) and echocardiography. Serological main indicative findings were: elevation of inflammatory markers, ANA (Anti-Nuclear Antibodies) titers = 1:320 (indirect immune-fluorescence – IIF – assay on HEp-2), homogeneous/fine speckled pattern, anti-dsDNA titers = 1:80 (IIF on Crithidia luciliae), negative ENA (Extractable Nuclear Antigens) and antibodies anti-citrulline, rheumatoid factor = 253 KU/l, normal C3-C4, negative HbsAg and anti-HCV, negative anticardiolipin antibodies IgG and IgM, negative anti-beta2GPI IgG and IgM. Amiodarone was discontinued and methylprednisolone was started, since the patient was severely ill. At discharge, after a month, the patient was better and pleuro-pericardical effusion was reduced. Readmitted few weeks later for bradyarithmia and worsening of dyspnoea, pericardial effusion was further reduced but he died for refractory congestive heart failure and pneumonia. Clinical picture (sierositis, neither skin nor kidney involvement), other typical side effects of amiodarone (hypothyroidism and lung interstitial pathology) and serological findings are suggestive of amiodarone-induced SLE.
References
Sarzi-Puttini P, Atzeni F, Capsoni F, et al. Drug-induced lupus erythematosus. Autoimmunity
; 8: 507-18
Amhad S. Lovastatin-induced lupus erythematosus. Arch Intern Med 1991; 151: 1667-8
Bannwarth B, Miremont G, Papapietro PM. Lupus-like syndrome associated with simvastatin
(letter). Arch Intern Med 1992; 152: 1093
Hanson J, Bossingham D. Lupus-like syndrome associated with simvastatin. Lancet 1998; 352: 1070
Sridhar MK, Abdulla A. Fatal lupus-like syndrome and ARDS induced by fluvastatin. Lancet
; 352: 114
Hydzik P, Szpak D. Side effects of HMG-Coa reductase inhibitors (statins). Lupus erythematosus induced by Atorvastatin therapy. Przegl Lek 2011; 68: 495-8
Khosla R, Butman AN, Hammer DF. Simvastatin-induced lupus erythematosus. South Med J
; 91: 873-4
Jimenez-Alonso J, Jaimez L, Sabio JM, et al. Atorvastatin-induced reversible positive antinuclear antibodies. Am J Med 2002; 112: 329-30
Noel B, Panizzon RG. Lupus-like syndrome associated with statin therapy. Dermatology 2004;
: 276-7
deJong HJ, Tervaert JW, Saldi SR, et al. Association between statin use and lupus-like syndrome using spontaneous reports. Semin Arthritis Rheum 2011: 41: 373-81
Ahmad A, Fletcher MT, Roy TM. Simvastatin-induced lupus-like syndrome. Tenn Med 2000;
: 21-2
Srivastava M, Rencic A, Diglio G, et al. Drug-induced, Ro/SSA-positive cutaneous lupus
erythematosus. Arch Dermatol 2003; 139: 45-9
Graziadei IW, Obermoser GE, Sepp NT, et al. Drug-induced lupus-like syndrome associated
with severe autoimmune hepatitis. Lupus 2003; 12: 409-12
Suchak R, Benson K, Swale V. Statin-induced Ro/SSA-positive subacute cutaneous lupus
erythematosus. Clin Exp Dermatol 2007; 32: 589-91
Moulis G, Béné J, Sommet A, et al; French Association of Pharmacovigilance Centres. Statin induced lupus: a case/non-case study in a nationwide pharmacovigilance database. Lupus 2012; 21: 885-9
Sheikhzadeh A, Schafer U, Schnabel A. Drug-induced lupus erythematosus by amiodarone.
Arch Intern Med 2002; 162: 834-6
Susano R, Caminal L, Ramos D, et al. Amiodarone induced lupus. Ann Rheum Dis 1999; 58: 655-6
Kundu AK. Amiodarone-induced systemic lupus erythematosus. J Assoc Physicians India 2003; 51: 216
Park SJ, Shin JI. Role of interleukin-12 and -18 in lupus-like syndrome patients with statin
use. Comment on: Association between statin use and lupus-like syndrome using spontaneous
reports. Semin Arthritis Rheum 2012; 41: e2-e3
AAVV. Case Records of the Massachusetts General Hospital (Case 35-1997). N Engl J Med
; 337: 1449-58
Harris L, McKenna WJ, Rowland E, et al. Side effects of long-term amiodarone therapy.
Circulation 1983; 67: 45-51
Gonzalez-Rothi RJ, Hannan SE, Hood I, et al. Amiodarone pulmonary toxicity presenting as
bilateral exudative pleural effusions. Chest 1987; 92: 179-82
Clarke B, Ward DE, Honey M. Pneumonitis with pleural and pericardial effusion and neuropathy during amiodarone therapy. Int J Cardiol 1985; 8: 81-8
Manolis AS, Tordjman T, Mack KD, et al. Atypical pulmonary and neurologic complications
of amiodarone in the same patient. Report of a case and review of the literature. Arch Intern
Med 1987; 147: 1805-7
Carmichael LC, Newman JH. Lymphocytic pleural exudate in a patient receiving amiodarone.
Br J Clin Pract 1996; 50: 228-30
Mittal SR, Maheshwari M. Amiodarone-induced exudative pleural effusion. A case report and
review of literature. Indian Heart J 2006; 58: 352-5
Uong V, Nugent K, Alalawi R, et al. Amiodarone-induced loculated pleural effusion: case report and review of the literature. Pharmacotherapy 2010; 30: 218
Bilge NSY, Gonullu E, Kasifoglu T, et al. Amiodarone-induced pleural fluid is not always
accompanied by a risk factor. Anadolu Kardiyol Derg 2012; 12: 281-2
De Groot RE, Willems LN, Dijkman JH. Interstitial lung disease with pleural effusion caused
by simvastatin. J Intern Med 1996; 239: 361-3
Huang LK, Tsai MJ, Tsai HC, et al. Statin-induced lung injury: diagnostic clue and outcome.
Postgrad Med J 2013; 89: 14-9
Kalomenidis I, Papiris S, Loukides S. Bilateral pleural effusions associated with pravastatin
treatment. Eur Respir 2007; 30: 1022
Kammer GM, Misrha N. Systemic lupus erythematosus in the elderly. Rheum Dis Clin North
Am 2000; 3
Trock D, Voinea A, Wolk J, et al. New-onset lupus presenting as serositis in an 80-year-old
woman. J Clin Rheumatol 2005; 11: 292-3
Chang WT, Hsieh TH, Liu MF. Systemic lupus erythematosus with initial presentation of
empyematous pleural effusion in an elderly male patient: a diagnostic challenge. J Microbiol
Immunol Infect 2012 May 18 [Epub ahead of print]
Published
Issue
Section
License
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution Non-Commercial 4.0 Licence that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. The Publication Agreement can be downloaded here, and should be signed by the Authors and sent to the Publisher when the article has been accepted for publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
- Authors are permitted to post their work online after publication (the article must link to publisher version, in html format)